MNDY — AI Stock Forecast & Price Targets
Published 9/9/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live MNDY price forecast →
MNDY is a high-quality SaaS franchise (89% gross margin, ~21% FCF margin, ~$616M net cash) trading at 12.5x forward P/E and 0.57 PEG after a -56% one-year drawdown, with a fresh -8% gap on 9/8 breaking the $86-88 accumulation floor. The setup favors staged accumulation into $78-84 given best-in-class unit economics and cheap valuation, but guided deceleration to 16-17%, NDR normalization to ~108%, SMB softness, and a cluster of sell-side target cuts (Cantor $90, Wells $120) argue against aggressive sizing before the 11/9 earnings print. Prior calls have run persistently optimistic on timing (0/8 directional hits, base targets +29% too high on average) — this report intentionally lowers base and stages entries deeper.
1-4 week view: Begin staged accumulation but do NOT front-load. Initial 1/3 position at $80-82 (RSI oversold + psychological support), add 1/3 at $76-78 (52-wk low complex retest), reserve 1/3 for either a $72 flush or a confirmed reclaim of $88-90 with volume. Invalidation: decisive weekly close below $70 (breaks the entire base) — cut to zero. Do not chase above $90 given 9/8 broken shelf and no earnings catalyst until 11/9. Size at 40-60% of standard given 5.8 ATR and 17% short float amplifying both tails.
1-6 month view: Base case is a range trade $78-108 into 11/9 earnings, with directional resolution driven by Q3 print and FY26 guide. Bull scenario: RPO/cRPO conversion translates to reported re-acceleration, AI ARR hits 15-20% of net-new bookings, NDR stabilizes — stock re-rates to $115-125 (15-16x forward P/E, still below prior). Bear scenario: SMB churn accelerates, NDR breaks 108%, FY26 guide cut below 16% — retest 52-wk low $57-65 (~11x forward P/E trough). Expected 6-month return range: -20% to +45% from $83.67 with fat tails. What would change my mind: a confirmed pre-announcement, another downgrade cluster taking consensus below $95, or MSFT/Atlassian competitive data points on SMB take rates.
1-3 year view: If the AI Work Platform pivot delivers seats-plus-credits monetization at scale and multi-product attach (CRM, dev, service) sustains 115%+ enterprise NDR, MNDY compounds revenue at 18-22% with 20%+ FCF margins — a $150-200 stock is plausible on 20x forward FCF and mid-teens growth. Structural risk: Microsoft's Copilot/Loop/Planner bundling and Atlassian's cross-sell erode SMB pricing power at exactly the segment MNDY has admitted is soft. Israel HQ geopolitical tail risk is real but discountable at 1.12 beta. Franchise quality (89% GM, ROIC 14.6%, net cash) supports patient capital, but the multiple compression from 35x to 12x forward P/E is a warning that the market is questioning terminal growth, not celebrating it.
MNDY continues to deliver best-in-class SaaS economics: TTM revenue $1.37B (+24% YoY), gross margin 88.7%, FCF $285M (~21% margin), and ROIC 14.6%. Q2 2026 revenue of $365M grew ~22% Q/Q pace but net income compressed to $3.5M as operating margin held at ~5.5% GAAP (management guides ~15% non-GAAP). RPO $937M (+34%) and cRPO $750M (+27%) are outpacing reported revenue, a leading indicator that bookings strength could translate into H2 revenue conversion. The balance sheet remains a fortress despite the $870M buyback drawdown — $853M cash vs $237M debt (net cash ~$616M) and current ratio 1.53. What's broken: net income swung from $77M in Q4 2025 to $3.5M in Q2 2026 as operating leverage inflection stalled; stockholders' equity fell from $1.25B to $618M in two quarters as buybacks consumed cash; and forward revenue growth is decelerating from 24% TTM to 16-17% guide, with NDR normalizing to ~108% and explicit SMB softness. Valuation of 12.5x forward P/E and 0.57 PEG is cheap for a franchise of this quality — the market is pricing execution risk on the AI pivot rather than franchise deterioration.
Multi-timeframe picture is unambiguously negative near-term. On the 1h chart price broke the $86-88 shelf on 9/8 with an -8% gap to $83.67 on 5.8 ATR volatility; the model's 1h forecast band ($82-91) straddles the current print with no directional edge. Daily chart shows the stock -9.3% below SMA20, -3.1% below SMA50, and -11.6% below SMA200, with RSI 41.9 — oversold but not washed out. 4h/1d/1wk charts all show price sitting near the low end of the six-month range ($57-101), with the daily/weekly forecast bands pointing sharply higher ($173-180) but that AI signal has been unreliable on this name (prior bull targets $130-138 persistently failed to print). Key levels: immediate resistance $88 (broken shelf), then $91-94 (prior consolidation); support at $80 psychological, then $72-78 (52-wk low complex at $57.50). Short float 17% / 3.9 days-to-cover is a double-edged setup — squeeze fuel on any positive catalyst but gap-down amplifier on bad news. The forecast reliability check confirms: 1d directional accuracy 71% vs 70% baseline (no edge), 1wk 67% vs 67% (no edge) — do not lean on the AI band for timing.
Signal: (1) The 9/8 -8% session capped a cluster of sell-side actions — Cantor downgraded to Neutral with $90 PT (from $112), Wells cut to $120 (from $130), UBS held Neutral at $95. Consensus target dispersion is wide ($90-165, average ~$106-117), signaling active estimate resets. (2) Q2 print beat but the stock sold off ~10% post-earnings on the deceleration guide to 16-17% and NDR normalization to ~108% — a classic guidance-driven de-rating. (3) 20% RIF framed as AI transition — execution risk on capital reallocation. (4) Insider signal is a small $62k CRO sale on 9/2 (noise, not conviction). Noise: retail sentiment on social is 100% bullish but volume is tiny (19 messages); Simply Wall St fair value estimates of $221 look stale/optimistic; the volatility/sentiment framework flag confirms MNDY was likely shortlisted for statistical range-expansion reasons, not a positive catalyst. Next earnings 11/9 (~61 days out) is the pivotal event — no near-term binary catalysts before then.
- AI Work Platform ARR doubling sequentially; target 15-20% of net-new bookings by year-end via seats-plus-credits monetization (Q2 disclosure)
- RPO $937M (+34%) and cRPO $750M (+27%) outpacing reported revenue — leading indicator of H2 conversion
- Multi-product attach: monday CRM, dev, service driving 115% NDR in >$50k enterprise cohort
- GAAP operating margin inflection post-20% RIF: non-GAAP guide raised to ~15% for FY26
- $616M net cash + $285M annual FCF supports M&A tuck-ins or renewed buyback authorization post $870M program exhaustion
- Enterprise up-market motion — dilution of SMB mix could stabilize NDR toward 110%+ over 4-6 quarters
- Guided deceleration from 24% TTM to 16-17% with NDR normalizing to ~108% — SMB softness is the single biggest swing factor
- $870M buyback exhausted removes technical demand backstop; cash drew from $1.53B to $853M in two quarters
- Sell-side downgrade cluster (Cantor $90, Wells $120, UBS $95) signals further estimate resets possible into 11/9 earnings
- 17% short float / 3.9 days-to-cover amplifies gap-down risk on any Q3 guide disappointment
- Microsoft (Copilot/Loop/Planner) and Atlassian competitive encroachment pressuring SMB pricing power at exactly the soft segment
- AI transition execution risk following 20% RIF — capital and talent reallocation cadence unproven
- Israel HQ geopolitical tail risk; beta 1.12 vulnerable in any risk-off tape
- Forecast model unreliable on this name — 0/8 recent calls directionally correct, base targets ran +29% optimistic
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord